Temat: "Transplantation Conditioning" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience.
Autorzy:: Stavi V; Soroka Medical Center, Beer Sheva 84101, Israel.
Khaire N; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
Lipton JH; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
Kumar R; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 26; Vol. 31 (3), pp. 1246-1252. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Case Reports
MeSH Terms:: Anemia, Aplastic*/therapy
Hematopoietic Stem Cell Transplantation*/methods
Graft vs Host Disease*
Humans ; Retrospective Studies ; Transplantation Conditioning/methods

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes.
Autorzy:: Chen J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Pang A; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhao Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Liu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Ma R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Wei J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Chen X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Yang D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhai W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Ma Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Han M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhou J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 293-299.
Typ publikacji:: Journal Article
MeSH Terms:: Graft Rejection/*physiopathology
Hematopoietic Stem Cell Transplantation/*adverse effects
Transplantation Conditioning/*adverse effects
Transplantation, Homologous/*adverse effects
Adolescent ; Adult ; Case-Control Studies ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Male ; Middle Aged ; Risk Factors ; Transplantation Conditioning/methods ; Transplantation, Homologous/methods ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study.
Autorzy:: Gao L; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Yang L; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Tongren Hospital Shanghai Jiao Tong University School of Medicine, 111 Xianxia Road, Shanghai, China.
Zhou S; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Zhu W; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Han Y; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Chen S; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Xue S; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Wang Y; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Qiu H; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. .; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China. .
Wu D; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. .; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China. .
Wu X; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. .; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China. .; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2024 Jan 29; Vol. 15 (1), pp. 24. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Myelodysplastic Syndromes*/therapy
Aged ; Humans ; Middle Aged ; Retrospective Studies ; Transplantation Conditioning ; China

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Second haploidentical bone marrow transplantation with antithymocyte antibody-containing conditioning regimen for graft failure in eight patients with severe aplastic anemia.
Autorzy:: Zhang C; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, No. 467, Zhongshan Road, ShaHeKou District, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Blood Stem Cell Transplantation Institute, Dalian Key Laboratory of Hematology, Diamond Bay Institute of Hematology, The Second Hospital of Dalian Medical University, Dalian, 116027, China.
Hou Y; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, No. 467, Zhongshan Road, ShaHeKou District, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Blood Stem Cell Transplantation Institute, Dalian Key Laboratory of Hematology, Diamond Bay Institute of Hematology, The Second Hospital of Dalian Medical University, Dalian, 116027, China.
Yang Y; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, No. 467, Zhongshan Road, ShaHeKou District, Dalian, 116027, China.
Zhang J; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, No. 467, Zhongshan Road, ShaHeKou District, Dalian, 116027, China. .; Department of Pediatric, Pediatric Oncology and Hematology Center, The Second Hospital of Dalian Medical University, Dalian, 116027, China. .
Zheng X; Department of Hematology, Air Force Medical Center, PLA, No. 3 Fuchen Road, Haidian District, Beijing, 100142, China. .
Yan J; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, No. 467, Zhongshan Road, ShaHeKou District, Dalian, 116027, China. .; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Blood Stem Cell Transplantation Institute, Dalian Key Laboratory of Hematology, Diamond Bay Institute of Hematology, The Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Department of Pediatric, Pediatric Oncology and Hematology Center, The Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 27; Vol. 14 (1), pp. 2293. Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Anemia, Aplastic*/therapy
Hematopoietic Stem Cell Transplantation*
Graft vs Host Disease*/etiology
Humans ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Adult ; Bone Marrow Transplantation ; Retrospective Studies ; Antilymphocyte Serum/therapeutic use ; Transplantation Conditioning ; Cyclophosphamide

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes.
Autorzy:: Liu H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zou H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Shan D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Liu W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Huang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Sui W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Deng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Wang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Lv R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Fu M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Xu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
An G; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zhao Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zou D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (2), pp. e6965.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/methods
Lymphoma, Non-Hodgkin*/drug therapy
Humans ; Carmustine/adverse effects ; Gemcitabine ; Melphalan/adverse effects ; Retrospective Studies ; Transplantation, Autologous/methods ; Cyclophosphamide/therapeutic use ; Etoposide/adverse effects ; Cytarabine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Transplantation Conditioning/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Ten-Year Trends of Hematopoietic Stem Cell Transplantation in Korean Pediatric Cancer from the National Health Insurance Claims Data.
Autorzy:: Kim H; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim HJ; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jo Y; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Yoon SH; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Koh YK; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Pediatrics, Chosun University College of Medicine, Gwangju, Korea.
Kang S; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Koh KN; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Im HJ; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Pokaż więcej
Źródło:: Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 294-304. Date of Electronic Publication: 2023 Sep 07.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Neoplasms*/epidemiology
Neoplasms*/therapy
Adolescent ; Humans ; Child ; Registries ; Transplantation Conditioning ; Republic of Korea/epidemiology ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin.
Autorzy:: Lisak M; Department of Hematology and Coagulation, Sahlgrenska University Hospital, Bruna stråket 5, plan 5, 413 45, Gothenburg, Sweden. .; Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden. .
Nicklasson M; Department of Hematology and Coagulation, Sahlgrenska University Hospital, Bruna stråket 5, plan 5, 413 45, Gothenburg, Sweden.
Palmason R; Department of Hematology, Skane University Hospital, Lund, Sweden.
Wichert S; Department of Hematology, Skane University Hospital, Lund, Sweden.
Isaksson C; Department of Hematology, Norrland University Hospital, Umeå, Sweden.
Andersson PO; Department of Hematology and Coagulation, Sahlgrenska University Hospital, Bruna stråket 5, plan 5, 413 45, Gothenburg, Sweden.; Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Johansson JE; Department of Hematology and Coagulation, Sahlgrenska University Hospital, Bruna stråket 5, plan 5, 413 45, Gothenburg, Sweden.; Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Lenhoff S; Department of Hematology, Skane University Hospital, Lund, Sweden.
Brune M; Department of Hematology and Coagulation, Sahlgrenska University Hospital, Bruna stråket 5, plan 5, 413 45, Gothenburg, Sweden.; Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Hansson M; Department of Hematology and Coagulation, Sahlgrenska University Hospital, Bruna stråket 5, plan 5, 413 45, Gothenburg, Sweden.; Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.; Department of Hematology, Skane University Hospital, Lund, Sweden.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Dec 20; Vol. 13 (1), pp. 22777. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Leukemia, Myeloid, Acute*/therapy
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/epidemiology
Humans ; Cyclosporine/therapeutic use ; Antilymphocyte Serum/therapeutic use ; Unrelated Donors ; Acute Disease ; Recurrence ; Retrospective Studies ; Transplantation Conditioning/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Application prospect of low-dose porcine anti-thymocyte globulin in HLA-matched sibling donor transplantation.
Autorzy:: Chen X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Ma Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Zhang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Zhai W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Ma Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Pang A; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Yang D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Wei J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Song Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Han M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Tianjin, People's Republic of China.; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2212943.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/methods
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/pathology
Female ; Humans ; Animals ; Swine ; Antilymphocyte Serum/therapeutic use ; Siblings ; Neoplasm Recurrence, Local ; Chronic Disease ; Transplantation Conditioning/adverse effects ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia.
Autorzy:: Cao J; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Xu X; Department of Oncology, The First Affiliated Hospital of Ningbo University, Ningbo, People's Republic of China.
Lu Y; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Wang T; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Chen D; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Li S; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Liu X; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Ye P; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Zheng ZZ; Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, People's Republic of China.
Pei R; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2223873.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/drug therapy
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematologic Neoplasms*/therapy
Adult ; Humans ; Child ; Cyclophosphamide/therapeutic use ; Busulfan/therapeutic use ; Antilymphocyte Serum/therapeutic use ; Acute Disease ; Transplantation Conditioning ; Cytarabine/therapeutic use ; Recurrence ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Can doses of post-transplantation cyclophosphamide in haploidentical stem cell allografts be reduced?
Autorzy:: Olivares-Gazca JC; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México.
Pastelín-Martínez ML; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Anáhuac Puebla, Puebla, México.
Montes-Robles MA; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Anáhuac Puebla, Puebla, México.
Gallardo-Pérez MM; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México.
Hernández-Flores EJ; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México.
Robles-Nasta M; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México.
Sánchez-Bonilla D; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México.
Ruiz-Delgado GJ; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México.
Ruiz-Argüelles GJ; Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México.; Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2242176.
Typ publikacji:: Journal Article
MeSH Terms:: Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans ; Prospective Studies ; Cyclophosphamide ; Transplantation Conditioning/methods ; Allografts ; Stem Cells ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Transplantation Conditioning"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język